Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy
PHASE1CompletedINTERVENTIONAL
Enrollment
51
Participants
Timeline
Start Date
July 31, 1995
Study Completion Date
January 31, 2002
Conditions
Breast NeoplasmNeoplasm Metastasis
Interventions
PROCEDURE
Autologous T cells
DRUG
Interleukin-2
Trial Locations (1)
20892
National Cancer Institute (NCI), Bethesda
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00001440 - Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy | Biotech Hunter | Biotech Hunter